Non-small Cell Lung Cancer Adenocarcinoma
1 clinical trials · Condition
◉ Watch Non-small Cell Lung Cancer Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma (NCT03696212) | Arrys Therapeutics | 2019-01-08 |
Track Non-small Cell Lung Cancer Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.